These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18709567)

  • 1. U-shaped dose response in behavioral pharmacology: historical foundations.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(7):591-8. PubMed ID: 18709567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response features of neuroprotective agents: an integrative summary.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(4):253-348. PubMed ID: 18432419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease drugs: an application of the hormetic dose-response model.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(5):419-51. PubMed ID: 18568864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and u-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(7):579-90. PubMed ID: 18709566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of behavioral pharmacology.
    Barrett JE
    Mol Interv; 2002 Dec; 2(8):470-5. PubMed ID: 14993396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological enhancement of neuronal survival.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(4):349-89. PubMed ID: 18432420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical blunders: how toxicology got the dose-response relationship half right.
    Calabrese EJ
    Cell Mol Biol (Noisy-le-grand); 2005 Dec; 51(7):643-54. PubMed ID: 16359616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormesis, adaptation, and the sandpile model.
    Stark M
    Crit Rev Toxicol; 2008; 38(7):641-4. PubMed ID: 18709573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein efflux transporter activity often displays biphasic dose-response relationships.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(5):473-87. PubMed ID: 18568867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytes: adaptive responses to low doses of neurotoxins.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(5):463-71. PubMed ID: 18568866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule-controlled behaviors as determinants of drug response.
    Morse WH
    Fed Proc; 1975 Aug; 34(9):1868-9. PubMed ID: 1149895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormesis: why it is important to toxicology and toxicologists.
    Calabrese EJ
    Environ Toxicol Chem; 2008 Jul; 27(7):1451-74. PubMed ID: 18275256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2005; 35(2-3):89-295. PubMed ID: 15839378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the hormetic nature of homeopathic interventions through stress response pathways.
    Rattan SI; Deva T
    Hum Exp Toxicol; 2010 Jul; 29(7):551-4. PubMed ID: 20558605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of drug-taking behavior by schedules of reinforcement.
    Kelleher RT; Goldberg SR
    Pharmacol Rev; 1975 Sep; 27(3):291-9. PubMed ID: 817303
    [No Abstract]   [Full Text] [Related]  

  • 16. Stress biology and hormesis: the Yerkes-Dodson law in psychology--a special case of the hormesis dose response.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(5):453-62. PubMed ID: 18568865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction and dose response: the psychomotor stimulant theory of addiction reveals that hormetic dose responses are dominant.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(7):599-617. PubMed ID: 18709568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug effects and concurrent performances.
    Catania AC
    Pharmacol Rev; 1975 Sep; 27(3):385-94. PubMed ID: 1223911
    [No Abstract]   [Full Text] [Related]  

  • 20. When to respond? And how much? Temporal control and response output on mixed-fixed-interval schedules with unequally probable components.
    Whitaker S; Lowe CF; Wearden JH
    Behav Processes; 2008 Jan; 77(1):33-42. PubMed ID: 17628349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.